EUVIMEDEUVIMED entdecken
Open Access

Doxorubicin‐Loaded Microrobots for Targeted Drug Delivery and Anticancer Therapy

Sudipta Mallick iD, Ramadan Abouomar, David Rivas, Max Sokolich, Fatma Ceren Kirmizitas, Aditya Dutta, Sambeeta Das iD

Advanced Healthcare Materials · 2023-11 · 12 (28)

DOI: 10.1002/adhm.202300939 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 09.07.2023. Verfasst von Sudipta Mallick und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mechanical Engineering, University of Delaware, Newark, DE, 19716, USA. Hauptthemen laut MEDLINE: Doxorubicin, Antineoplastic Agents. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences, National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Micro‐sized magnetic particles (also known as microrobots [MRs]) have recently been shown to have potential applications for numerous biomedical applications like drug delivery, microengineering, and single cell manipulation. Interdisciplinary studies have demonstrated the ability of these tiny particles to actuate under the action of a controlled magnetic field that not only drive MRs in a desired trajectory but also precisely deliver therapeutic payload to the target site. Additionally, optimal concentrations of therapeutic molecules can also be delivered to the desired site which is cost‐effective and safe especially in scenarios where drug dose‐related side effects are a concern. In this study, MRs are used to deliver anticancer drugs (doxorubicin) to cancer cells and subsequent cell death is evaluated in different cell lines (liver, prostate, and ovarian cancer cells). Cytocompatibility studies show that MRs are well‐tolerated and internalized by cancer cells. Doxorubicin (DOX) is chemically conjugated with MRs (DOX‐MRs) and magnetically steered toward cancer cells using the magnetic controller. Time‐lapsed video shows that cells shrink and eventually die when MRs are internalized by cells. Taken together, this study confirms that microrobots are promising couriers for targeted delivery of therapeutic biomolecules for cancer therapy and other non‐invasive procedures that require precise control.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinAntineoplastic AgentsMaleHumansDrug Delivery SystemsCell LineCell Death

Stichwörter der Autor:innen

cancer therapydoxorubicindrug deliverylivermicrorobotsovaryprostate

Substanzen

DoxorubicinAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Mechanical Engineering, University of Delaware, Newark, DE, 19716, USA.
  • Department of Animal and Food Sciences, University of Delaware, Newark, DE, 19716, USA.

ORCID-Profile: Sudipta Mallick, Sambeeta Das

Förderung

  • NIGMS NIH HHS
  • National Institute of General Medical Sciences
  • National Science Foundation

Zitieren

APA

Mallick, S., Abouomar, R., Rivas, D., Sokolich, M., Kirmizitas, F. C., Dutta, A., & Das, S. (2023). Doxorubicin‐Loaded Microrobots for Targeted Drug Delivery and Anticancer Therapy. Advanced Healthcare Materials, 12(28). https://doi.org/10.1002/adhm.202300939

Vancouver

Mallick S, Abouomar R, Rivas D, Sokolich M, Kirmizitas FC, Dutta A, et al. Doxorubicin‐Loaded Microrobots for Targeted Drug Delivery and Anticancer Therapy. Advanced Healthcare Materials. 2023;12(28). doi:10.1002/adhm.202300939

BibTeX
@article{Mallick2023,
  author = {Mallick, Sudipta and Abouomar, Ramadan and Rivas, David and Sokolich, Max and Kirmizitas, Fatma Ceren and Dutta, Aditya and Das, Sambeeta},
  title = {Doxorubicin‐Loaded Microrobots for Targeted Drug Delivery and Anticancer Therapy},
  journal = {Advanced Healthcare Materials},
  year = {2023},
  volume = {12},
  number = {28},
  doi = {10.1002/adhm.202300939}
}
Kostenlos starten →